Brain conditions account for 14% of Aviva's CI pay outs in 2022

Represented 9% of IP claims last year

Jaskeet Briah
clock • 2 min read

Brain conditions including a stroke, multiple sclerosis (MS) and benign brain tumours, accounted for 14% of Aviva’s claims pay outs for critical illness (CI) in 2022.

The provider paid out over £1.07bn for claims across life insurance, CI, income protection (IP) and other individual protection policies last year. Aviva noted diseases that affect the brain can happen at any age, with the youngest adult CI claimant in 2022 now being revealed to be 21 years old and claiming for a benign brain tumour. The average age of customers claiming for CI due to brain conditions was 42 for MS, 45 for a benign brain tumour, 50 for a stroke, and 51 for brain cancer. MS represented the brain condition with the largest claims payment out of all four of these at...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

Little change in economic inactivity: ONS

Little change in economic inactivity: ONS

Number of vacancies decreasing

Jaskeet Briah
clock 17 December 2024 • 3 min read
Beagle Street adds protection offering to OneFamily platform

Beagle Street adds protection offering to OneFamily platform

Replatformed by iPipeline

Jaskeet Briah
clock 12 December 2024 • 1 min read
Young adults turning to social media for health information

Young adults turning to social media for health information

Half of adults have self-diagnosed in the last year

Jaskeet Briah
clock 11 December 2024 • 3 min read